Biology Reference
In-Depth Information
117. Hsieh MM, Hegde V, Kelley MR, Deutsch WA. Activation of
APE/Ref-1 redox activity is mediated by reactive oxygen species
and PKC phosphorylation. Nucleic Acids Res 2001;
138. Sengupta S, Shimamoto A, Koshiji M, et al. Tumor suppressor
p53 represses
transcription of RECQ4 helicase. Oncogene
22.
118. Vasko MR, Guo C, Kelley MR. The multifunctional DNA repair/
redox enzyme Ape1/Ref-1 promotes survival of neurons after
oxidative stress. DNA Repair (Amst) 2005;
(14):3116
48.
139. Grombacher T, Eichhorn U, Kaina B. p53 is involved in regulation
of the DNA repair gene O6-methylguanine-DNA methyl-
transferase (MGMT) by DNA damaging agents. Oncogene
1998;
2005;
24
(10):1738
e
29
e
79.
119. Zou GM, Luo MH, Reed A, Kelley MR, Yoder MC. Ape1 regu-
lates hematopoietic differentiation of embryonic stem cells
through its redox functional domain. Blood 2007;
(3):367
4
e
51.
140. Rafferty JA, Clarke AR, Sellappan D, Koref MS, Frayling IM,
Margison GP. Induction of murine O6-alkylguanine-DNA-
alkyltransferase in response to ionising radiation is p53 gene dose
dependent. Oncogene 1996;
(7):845
17
e
22.
120. Fishel ML, Kelley MR. The DNA base excision repair protein
Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol
Aspects Med 2007;
(5):1917
109
e
7.
141. Lavon I, Fuchs D, Zrihan D, et al. Novel mechanism whereby
nuclear factor kappaB mediates DNA damage repair through
regulation
12
(3):693
e
95.
121. Bapat A, Fishel M, Kelley MR. Going ape as an approach to
cancer therapeutics. Antioxid Redox Signal 2009;
28
(3-4):375
e
of
O(6)-methylguanine-DNA-methyltransferase.
68.
122. Sengupta S, Harris CC. p53: traffic cop at the crossroads of DNA
repair and recombination. Nat Rev Mol Cell Biol 2005;
:651
11
e
9.
142. Hayakawa J, Mittal S, Wang Y, et al. Identification of promoters
bound by c-Jun/ATF2 during rapid large-scale gene activation
following genotoxic stress. Mol Cell 2004;
Cancer Res 2007;
(18):8952
67
e
(1):44
55.
6
e
123. Helton ES, Chen X. p53 modulation of
the DNA damage
35.
143. Humbert O, Achour I, Lautier D, Laurent G, Salles B. hMSH2
expression is driven by AP1-dependent regulation through
phorbol-ester exposure. Nucleic Acids Res 2003;
16
(4):521
e
96.
124. Zurer I, Hofseth LJ, Cohen Y, et al. The role of p53 in base excision
repair following genotoxic stress. Carcinogenesis 2004;
response. J Cell Biochem 2007;
100
(4):883
e
19.
125. Zaky A, Busso C, Izumi T, et al. Regulation of the human AP-
endonuclease (APE1/Ref-1) expression by the tumor suppressor
p53 in response to DNA damage. Nucleic Acids Res 2008;
(1):11
25
e
34.
144. Li Q, Zhang L, Tsang B, Gardner K, Bostick-Bruton F, Reed E.
Phorbol ester exposure activates an AP-1-mediated increase in
ERCC-1 messenger RNA expression in human ovarian tumor
cells. Cell Mol Life Sci 1999;
(19):5627
31
e
(5):
36
66.
126. He F, Yang XP, Srivastava DK, Wilson SH. DNA polymerase beta
gene expression: the promoter activator CREB-1 is upregulated in
Chinese hamster ovary cells by DNA alkylating agent-induced
stress. Biol Chem 2003;
1555
e
66.
145. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, Kelley MR. The
apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair
enzyme is elevated in premalignant and malignant cervical
cancer. Anticancer Res 1997;
(3):456
55
e
23.
127. Adimoolam S, Ford JM. p53 and DNA damage-inducible
expression of the xeroderma pigmentosum group C gene. Proc
Natl Acad Sci USA 2002;
384
(1):19
e
9.
146. Evans AR, Limp-Foster M, Kelley MR. Going APE over Ref-1.
Mutat Res 2000;
(5B):3713
17
e
108.
147. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1
(APE1) expression and prognostic significance in osteosarcoma:
enhanced sensitivity of osteosarcoma to DNA damaging agents
using silencing RNA APE1 expression inhibition. Mol Cancer Ther
2004;
(2):83
461
e
90.
128. Tan T, Chu G. p53 Binds and activates the xeroderma pigmen-
tosum DDB2 gene in humans but not mice. Mol Cell Biol
2002;
(20):12985
99
e
54.
129. Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression of the p48
xeroderma pigmentosumgene is p53-dependent and is involved in
global genomic repair. Proc Natl Acad Sci USA 1999;
(10):3247
22
e
86.
148. Moore DH, Michael H, Tritt R, Parsons SH, Kelley MR. Alterations
in the expression of the DNA repair/redox enzyme APE/ref-1 in
epithelial ovarian cancers. Clin Cancer Res 2000;
3
(6):679
e
8.
130. Hollander MC, Philburn RT, Patterson AD, et al. Deletion of XPC
leads to lung tumors in mice and is associated with early events
in human lung carcinogenesis. Proc Natl Acad Sci USA
2005;
(2):424
96
e
9.
149. Merluzzi S, Gri G, Gattei V, Pagano M, Pucillo C. APE/Ref-1
makes fine-tuning of CD40-induced B cell proliferation. Mol
Immunol 2008;
(2):602
6
e
5.
131. Chen J, Sadowski I. Identification of the mismatch repair genes
PMS2 and MLH1 as p53 target genes by using serial analysis of
binding elements. Proc Natl Acad Sci USA 2005;
(37):13200
102
e
9.
150. Mihaylova VT, Bindra RS, Yuan J, et al. Decreased expression of
the DNA mismatch repair gene Mlh1 under hypoxic stress in
mammalian cells. Mol Cell Biol 2003;
(14):3731
45
e
8.
132. Scherer SJ, Maier SM, Seifert M, et al. p53 and c-Jun functionally
synergize in the regulation of the DNA repair gene hMSH2 in
response to UV. J Biol Chem 2000;
(13):4813
102
e
73.
151. Damia G, D'Incalci M. Targeting DNA repair as a promising
approach in cancer therapy. Eur J Cancer 2007;
23
(9):3265
e
801.
152. Madhusudan S, Hickson ID. DNA repair inhibition: a selective
tumour targeting strategy. Trends Mol Med 2005;
43
(12):1791
e
73.
133. Xu J, Morris GF. p53-mediated regulation of proliferating cell
nuclear antigen expression in cells exposed to ionizing radiation.
Mol Cell Biol 1999;
(48):37469
275
e
11.
153. Kelley MR, Fishel ML. DNA repair proteins as molecular targets
for cancer therapeutics. Anticancer Agents Med Chem 2008;
(11):503
11
e
20.
134. Lu X, Lozano G, Donehower LA. Activities of wildtype and
mutant p53 in suppression of homologous recombination as
measured by a retroviral vector system. Mutat Res 2003;
19
(1):12
e
(4):
8
25.
154. McEligot AJ, Yang S, Meyskens Jr FL. Redox regulation by
intrinsic species and extrinsic nutrients in normal and cancer
cells. Annu Rev Nutr 2005;
417
e
522
83.
135. Bishop AJ, Hollander MC, Kosaras B, Sidman RL, Fornace Jr AJ,
Schiestl RH. Atm-, p53-, and Gadd45a-deficient mice show an
increased frequency of homologous recombination at different
stages during development. Cancer Res 2003;
(1-2):69
e
95.
155. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through
dietary antioxidants: progress and promise. Antioxid Redox Signal
2008;
25
:261
e
510.
156. Messina M, Kucuk O, Lampe JW. An overview of the health effects
of isoflavones with an emphasis on prostate cancer risk and
prostate-specific antigen levels. J AOAC Int 2006;
(3):475
10
e
43.
136. Arias-Lopez C, Lazaro-Trueba I, Kerr P, et al. p53 modulates
homologous recombination by transcriptional regulation of the
RAD51 gene. EMBO Rep 2006;
(17):5335
63
e
34.
157. Raffoul JJ, Banerjee S, Singh-Gupta V, et al. Down-regulation of
apurinic/apyrimidinic endonuclease 1/redox factor-1 expression
by soy isoflavones enhances prostate cancer radiotherapy in vitro
and in vivo. Cancer Res 2007;
(4):1121
89
e
24.
137. Yamabe Y, Shimamoto A, Goto M, Yokota J, Sugawara M,
Furuichi Y. Sp1-mediated transcription of theWerner helicase gene
is modulated by Rb and p53. Mol Cell Biol 1998;
(2):219
7
e
18
(11):6191
e
200.
67
(5):2141
e
9.
